Eesti - eesti - Ravimiamet

viasana uab - sunitiniib - kõvakapsel - 25mg 30tk

Eesti - eesti - Ravimiamet

viasana uab - sunitiniib - kõvakapsel - 50mg 30tk

Eesti - eesti - Ravimiamet

viasana uab - sunitiniib - kõvakapsel - 12,5mg 30tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

biomarin international limited - valoctocogene roxaparvovec - antihemorraagilised ained - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Eesti - eesti - Ravimiamet

lv system service sia - sunitiniib - kõvakapsel - 12,5mg 30tk

Eesti - eesti - Ravimiamet

lv system service sia - sunitiniib - kõvakapsel - 50mg 30tk; 50mg 28tk

Eesti - eesti - Ravimiamet

pfizer enterprises sarl - idarubitsiin - kõvakapsel - 5mg 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

csl behring gmbh - etranacogene dezaparvovec - hemofiilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.

Euroopa Liit - eesti - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolaktoon - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.